RV5075A-MF6793
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RV5075A-MF6793, covering 2025-11-24 to 2025-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Effects of the Product RV5075A-MF6793 in Diabetic Patients Presenting Foot Xerosis and Superficial Fissures, an Exploratory Study. [NA]